Legato Capital Management »

Avita Therapeutics shares owned by Legato Capital Management

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Legato Capital Management from 13F filings

Historical chart of Legato Capital Management investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Legato Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Legato Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $851k 79k 10.72

More positions owned by Legato Capital Management

UFP Technologies (UFPT)
Ies Hldgs (IESC)
Apple (AAPL)
Argan (AGX)
ePlus (PLUS)
Agilysys (AGYS)
Broadcom (AVGO)
Bgc Group Inc Cl A (BGC)
Stonex Group (SNEX)
Microsoft Corporation (MSFT)
LSI Industries (LYTS)
Accenture (ACN)
Winmark Corporation (WINA)
Stryker Corporation (SYK)
Intercontinental Exchange (ICE)

View all positions for Legato Capital Management

Top funds holding Avita Therapeutics

BlackRock
Vanguard Group
Geode Capital Management
State Street Corporation
Soleus Capital Management
Essex Investment Management
Morgan Stanley
Goldman Sachs Group
D. E. Shaw & Co
Legato Capital Management
Citadel Advisors
AWM Investment Company
Nuveen Asset Management
Charles Schwab Investment Management
Jane Street

View all funds holding Avita Therapeutics